A ketogenic diet may enhance CAR T cell therapy, a personalized cancer treatment. Researchers at Penn Medicine found that elevated beta-hydroxybutyrate levels in the diet improve tumor control and survival in laboratory mice. The team identified a ketogenic diet as key to improving CAR T cell expansion and activation.
The findings are promising and are being tested in a Phase I clinical trial. However, results are preliminary and more evidence is needed before dietary recommendations can be made.
Source: https://www.devdiscourse.com/article/health/3186633-dietary-supplement-boosts-car-t-cell-therapy-a-new-hope-in-cancer-treatment